Yeah-Sil Moon

Yeah-Sil Moon is a leading U.S. and Korean patent attorney as recognized by Chambers, Super Lawyers, and The New York Times. She has 25 years of experience in all areas of patent law, including litigation, prosecution, opinion, and portfolio strategy for clients in the pharmaceutical, biotechnology, chemical, automobile, telecommunication, electronic, mechanical, and medical device sectors. Yeah-Sil has prosecuted and enforced patents worldwide for some of the most successful therapeutics. She assists Celgene Corporation in establishing its global patent portfolio including prosecution, strategic counseling, litigation, inter partes review (IPR), opposition, invalidation, and transactions for products including $billions/year drug REVLIMID®, POMALYST®, OTEZLA®, VIDAZA®, THALOMID® and ABRAXANE® for treating cancers and immune, inflammatory conditions.

Yeah-Sil has successfully defended patent infringement actions in various district courts and the ITC. She has represented Korean technology company SOLiD, Inc. and its U.S. distributor in complex patent disputes in the Northern District of California and obtained a jury verdict of non-infringement in 2015. Yeah-Sil also has in-depth experience in IPR. She represents SOLiD in an IPR challenging a patent related to a distributed antenna system, in which the PTAB granted institution. [1]